{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:06:29Z","timestamp":1793106389207,"version":"4.5.0"},"reference-count":44,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,12,24]],"date-time":"2008-12-24T00:00:00Z","timestamp":1230076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cellular Molecular Medi"],"published-print":{"date-parts":[[2010,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Minerval is an oleic acid synthetic analogue that impairs lung cancer (A549) cell proliferation upon modulation of the plasma membrane lipid structure and subsequent regulation of protein kinase C localization and activity. However, this mechanism does not fully explain the regression of tumours induced by this drug in animal models of cancer. Here we show that Minerval also induced apoptosis in Jurkat T\u2010lymphoblastic leukaemia and other cancer cells. Minerval inhibited proliferation of Jurkat cells, concomitant with a decrease of cyclin D3 and cdk2 (cyclin\u2010dependent kinase2). In addition, the changes that induced on Jurkat cell membrane organization caused clustering (capping) of the death receptor Fas (CD95), caspase\u20108 activation and initiation of the extrinsic apoptosis pathway, which finally resulted in programmed cell death. The present results suggest that the intrinsic pathway (associated with caspase\u20109 function) was activated downstream by caspase\u20108. In a xenograft model of human leukaemia, Minerval also inhibited tumour progression and induced tumour cell death. Studies carried out in a wide variety of cancer cell types demonstrated that apoptosis was the main molecular mechanism triggered by Minerval. This is the first report on the pro\u2010apoptotic activity of Minerval, and in part explains the effectiveness of this non\u2010toxic anticancer drug and its wide spectrum against different types of cancer.<\/jats:p>","DOI":"10.1111\/j.1582-4934.2008.00625.x","type":"journal-article","created":{"date-parts":[[2008,12,28]],"date-time":"2008-12-28T14:02:06Z","timestamp":1230472926000},"page":"659-670","source":"Crossref","is-referenced-by-count":47,"title":["Minerval induces apoptosis in Jurkat and other cancer cells"],"prefix":"10.1111","volume":"14","author":[{"given":"Victoria","family":"Llado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Casas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ter\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Higuera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Galm\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Saus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Besalduch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Busquets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo V.","family":"Escrib\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,4,21]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1080\/09687680410001716835"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.104.000778"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.088716"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M200356-JLR200"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M300092-JLR200"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M500520-JLR200"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M402061200"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.16.7595"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.21.11375"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.21.9767"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2657"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.00739"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7089561"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2005.11.004"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.105.011692"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj3130717"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64459-8"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1046-2023(03)00155-5"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/30.4.e15"},{"key":"e_1_2_6_21_2","first-page":"4308","article-title":"Overexpression of edg\u20102\/vzg\u20101 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid\u2010independent manner","volume":"5","author":"Furui T","year":"1999","journal-title":"Clin Cancer Res."},{"key":"e_1_2_6_22_2","first-page":"927","article-title":"Apoptosis in 7\u2010hydroxystaurosporine\u2010treated T lymphoblasts correlates with activation of cyclin\u2010dependent kinases 1 and 2","volume":"6","author":"Wang Q","year":"1995","journal-title":"Cell Growth Differ."},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00483a017"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1089\/104454902753759762"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.cad.0000185182.80227.48"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1186\/bcr1036"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-3084(99)00059-6"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-1494"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M502849200"},{"key":"e_1_2_6_30_2","first-page":"5344","article-title":"Identification of novel gene expression targets for the Ras association domain family 1 (RASSF1A) tumor suppressor gene in non\u2010small cell lung cancer and neuroblastoma","volume":"63","author":"Agathanggelou A","year":"2003","journal-title":"Cancer Res."},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00012523"},{"key":"e_1_2_6_32_2","first-page":"1822","article-title":"The lethal effects of cyclin\u2010dependent inhibitors in human leukemia cells proceed through phosphatidylinositol 3\u2010kinase\/Akt\u2010dependent process","volume":"63","author":"Yu C","year":"2003","journal-title":"Cancer Res."},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.13.12.1501"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-0808"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4402260"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005818917479"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(03)00284-2"},{"key":"e_1_2_6_38_2","first-page":"215","article-title":"Effects of C18 fatty acids on breast carcinoma cells in culture","volume":"7","author":"Begin ME","year":"1987","journal-title":"Anticancer Res."},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1207\/S15327914NC4601_04"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1054\/clnu.2002.0627"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910580604"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199012133232404"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2006.09.001"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2008.00281.x"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2007.00150.x"}],"container-title":["Journal of Cellular and Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1582-4934.2008.00625.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1582-4934.2008.00625.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T21:22:13Z","timestamp":1697318533000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1582-4934.2008.00625.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.1111\/j.1582-4934.2008.00625.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1582-4934.2008.00625.x","archive":["Portico"],"relation":{},"ISSN":["1582-1838","1582-4934"],"issn-type":[{"value":"1582-1838","type":"print"},{"value":"1582-4934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}